Traders bought shares of CVS Health Corporation (NYSE:CVS) on weakness during trading on Tuesday. $109.43 million flowed into the stock on the tick-up and $79.32 million flowed out of the stock on the tick-down, for a money net flow of $30.11 million into the stock. Of all equities tracked, CVS Health Corporation had the 13th highest net in-flow for the day. CVS Health Corporation traded down ($0.29) for the day and closed at $92.79

Several research firms recently issued reports on CVS. Citigroup Inc. lowered their price objective on CVS Health Corporation from $115.00 to $108.00 and set a “neutral” rating on the stock in a research report on Monday, August 8th. Argus reaffirmed a “buy” rating and issued a $120.00 price objective on shares of CVS Health Corporation in a research report on Thursday, August 4th. Mizuho upped their price objective on CVS Health Corporation from $108.00 to $111.00 and gave the company a “buy” rating in a research report on Thursday, August 4th. Leerink Swann reissued a “buy” rating on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Finally, Morgan Stanley reissued a “hold” rating and set a $104.00 price target on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Six equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $113.02.

The company’s 50-day moving average price is $96.15 and its 200 day moving average price is $98.59. The firm has a market capitalization of $98.93 billion and a PE ratio of 21.35.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.30 by $0.02. During the same quarter in the prior year, the firm earned $1.19 earnings per share. The business had revenue of $43.70 billion for the quarter, compared to analyst estimates of $44.28 billion. The company’s revenue for the quarter was up 17.6% on a year-over-year basis. On average, analysts expect that CVS Health Corporation will post $5.86 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 1st. Shareholders of record on Thursday, July 21st were given a $0.425 dividend. The ex-dividend date of this dividend was Tuesday, July 19th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.83%.

Other hedge funds and institutional investors have recently modified their holdings of the company. Sawtooth Asset Management Inc. increased its position in shares of CVS Health Corporation by 96.0% in the fourth quarter. Sawtooth Asset Management Inc. now owns 10,624 shares of the pharmacy operator’s stock worth $1,039,000 after buying an additional 5,203 shares during the period. Weatherly Asset Management L. P. increased its position in shares of CVS Health Corporation by 3.2% in the fourth quarter. Weatherly Asset Management L. P. now owns 21,881 shares of the pharmacy operator’s stock worth $2,139,000 after buying an additional 678 shares during the period. Private Advisor Group LLC increased its position in shares of CVS Health Corporation by 7.2% in the fourth quarter. Private Advisor Group LLC now owns 36,541 shares of the pharmacy operator’s stock worth $3,573,000 after buying an additional 2,449 shares during the period. Jacobson & Schmitt Advisors LLC increased its position in shares of CVS Health Corporation by 3.4% in the fourth quarter. Jacobson & Schmitt Advisors LLC now owns 40,638 shares of the pharmacy operator’s stock worth $3,973,000 after buying an additional 1,321 shares during the period. Finally, Mark Sheptoff Financial Planning LLC increased its position in shares of CVS Health Corporation by 2.8% in the fourth quarter. Mark Sheptoff Financial Planning LLC now owns 43,735 shares of the pharmacy operator’s stock worth $4,276,000 after buying an additional 1,206 shares during the period.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.